Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001437749-22-016469
Filing Date
2022-07-01
Accepted
2022-07-01 17:29:21
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM S-1/A navb20220630_s1a.htm S-1/A 1097315
2 EXHIBIT 23.1 ex_392027.htm EX-23.1 2731
3 navb20220211_s1img001.jpg GRAPHIC 2924
  Complete submission text file 0001437749-22-016469.txt   1105311
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-262691 | Film No.: 221062484
SIC: 2835 In Vitro & In Vivo Diagnostic Substances